DEFLAZACORT

UNII:	KR5YZ6AE4B
Type:	INGREDIENT SUBSTANCE
Formula:	C₂₅H₃₁NO₆
Preferred Substance Name:	DEFLAZACORT
InChIKey:	FBHSPRKOSMHSIF-GRMWVWQJSA-N
GSRS Full Record:	KR5YZ6AE4B i

14484-47-0
(11β,16β)-21-(Acetyloxy)-11-hydroxy-2′-methyl-5′H-pregna-1,4-dieno[17,16-d]oxazole-3,20-dione
11 β, 21-dihydroxy-2'-methyl-5' β-H-pregna-1,4-dieno[17,16d]oxazole-3,20-dione-21-acetate
2-((6aR,6bS,8aS,8bS,11aR,12aS,12bS)-7-hydroxy-6a,8a-dimethyl-10-methylene-4-oxo-1,2,4,6a,6b,7,8,8a,9,10,11a,12,12a,12b-tetradecahydro-8bH-naphtho[2',1':4,5]indeno[1,2-d]oxazol-8b-yl)-2-oxoethyl acetate
2-[(1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-6,9,13-trimethyl-16-oxo-5-oxa-7-azapentacyclo[10.8.0.0{2,9}.0{4,8}.0{13,18}]icosa-6,14,17-trien-8-yl]-2-oxoethyl acetate
5′H-Pregna-1,4-dieno[17,16-d]oxazole-3,20-dione, 21-(acetyloxy)-11-hydroxy-2′-methyl-, (11β,16β)-
Azacortinol
DL-458IT
Deflazacort
Deflazacort [INN]
Deflazacort [MART.]
Deflazacort [MI]
Deflazacort [ORANGE BOOK]
Deflazacort [USAN]
Deflazacort [USP-RS]
Deflazacort [WHO-DD]
EMFLAZA
L-5458
MDL-458
MDL458
[2-[(1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-6,9,13-trimethyl-16-oxo-5-oxa-7-azapentacyclo[10.8.0.02,9.04,8.013,18]icosa-6,14,17-trien-8-yl]-2-oxoethyl] acetate
[2-[(1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-6,9,13-trimethyl-16-oxo-5-oxa-7-azapentacyclo[10.8.0.02,9.04,8.013,18]icosa-6,14,17-trien-8-yl]-2-oxoethyl] acetate

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

DEFLAZACORT

Synonyms and Mappings

Resources